Heart Valve Voice US Praises Nomination Of Dr. Robert Califf as FDA Commissioner
Washington, DC/ November 12, 2021 — John Lewis, Executive Director of Heart Valve Voice US, issued the following statement regarding...
HVD Policy Task Force Comments on MCIT Repeal
Dear Administrator Brooks-LaSure: Heart Valve Voice US is submitting these comments on behalf of the Heart Valve Disease PolicyTask Force,...
7 Top TAVR Questions Answered By Someone Who’s Been Through It
One thing was certain immediately after my diagnosis of severe aortic stenosis (AS): I had questions! What exactly is aortic...
7 Ways to Make Life a Little Easier Before and After TAVR
When I first learned I had severe aortic stenosis and the only treatment was a heart valve replacement, I was...
I Was Told I Was Too Young for TAVR. Here’s Why I’m Glad I Pushed Back.
I was only 49 when I was diagnosed with severe aortic stenosis, a condition where the aortic valve doesn’t open...
Life After TAVR: Managing Uncertainty About My Valve’s Future
As a younger person living with valvular heart disease, I’ve learned to think of my aortic stenosis (AS) as a...
Comments on Cures 2.0 Discussion Draft
Honorable Diana DeGetteHonorable Fred Upton Comments on Cures 2.0 Discussion Draft Dear Representatives DeGette and Upton: Thank you for your...
#JustGo Campaign PSA Encourages Heart Valve Patients To Follow Up on Care
WASHINGTON, DC- Because of the Covid-19 pandemic, many heart valve patients have been unable or unwilling to follow up on...
Medicare Program; Medicare Coverage of Innovative Technology (MCIT) and Definition of “Reasonable and Necessary”; Delay of Effective Date (Docket No. CMS-2021-05490)
The Heart Valve Disease Policy Task Force represents a diverse group of patient,disease, and research advocacy groups with a shared...
HVVUS Urges Anthem To Revise Coverage Policies
Heart Valve Voice US is a patient advocacy organization focused on improving the diagnosis, management and treatment of heart valve...